Page last updated: 2024-11-10

usambarensine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

usambarensine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5281413
CHEMBL ID490322
CHEBI ID9910
SCHEMBL ID168639
MeSH IDM0192855

Synonyms (12)

Synonym
usambarensine
36150-14-8
C09249
chebi:9910 ,
CHEMBL490322 ,
17-norcorynan, 19,20-didehydro-16-(9h-pyrido(3,4-b)indol-1-yl)-, (19e)-
AC1NQYFE ,
(2r,3e,12bs)-3-ethylidene-2-(9h-pyrido[3,4-b]indol-1-ylmethyl)-2,4,6,7,12,12b-hexahydro-1h-indolo[2,3-a]quinolizine
SCHEMBL168639
surecn168639
Q27108512
DTXSID901317653

Research Excerpts

Overview

Usambarensine is a plant alkaloid isolated from the roots of Strychnos usambarensis collected in Central Africa.

ExcerptReferenceRelevance
"Usambarensine is a plant alkaloid isolated from the roots of Strychnos usambarensis collected in Central Africa. "( The plant alkaloid usambarensine intercalates into DNA and induces apoptosis in human HL60 leukemia cells.
Angenot, L; Bailly, C; Colson, P; Dassonneville, L; Frederich, M; Houssier, C; Mahieu, C; Tits, M; Wattez, N,
)
1.9

Treatment

ExcerptReferenceRelevance
"Usambarensine treatment is associated with a loss of cells in the G1 phase accompanied with a large increase in the sub-G1 region which is characteristic of apoptotic cells."( The plant alkaloid usambarensine intercalates into DNA and induces apoptosis in human HL60 leukemia cells.
Angenot, L; Bailly, C; Colson, P; Dassonneville, L; Frederich, M; Houssier, C; Mahieu, C; Tits, M; Wattez, N,
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
harmala alkaloidAny member of a class of naturally occurring alkaloids based on a 1-methyl-9H-beta-carboline skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID361155Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2/Indochina by [3H]hypoxanthine uptake2002Journal of natural products, Oct, Volume: 65, Issue:10
Antiplasmodial activity of alkaloids from various strychnos species.
AID361157Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum FCA 20/ Ghana by [3H]hypoxanthine uptake2002Journal of natural products, Oct, Volume: 65, Issue:10
Antiplasmodial activity of alkaloids from various strychnos species.
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID358512Selectivity index, ratio of IC50 for human WI38 cells to IC50 for chloroquine-sensitive Plasmodium falciparum FCA 20 Ghana2001Journal of natural products, Jan, Volume: 64, Issue:1
Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja.
AID358508Cytotoxicity against human KB cells by WST1 assay2001Journal of natural products, Jan, Volume: 64, Issue:1
Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja.
AID361154Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCB1-R/Colombia by [3H]hypoxanthine uptake2002Journal of natural products, Oct, Volume: 65, Issue:10
Antiplasmodial activity of alkaloids from various strychnos species.
AID358510Selectivity index, ratio of IC50 for human KB cells to IC50 for chloroquine-sensitive Plasmodium falciparum FCA 20 Ghana2001Journal of natural products, Jan, Volume: 64, Issue:1
Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja.
AID379452Antiplasmodial activity after 36 hrs against chloroquine-resistant Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake1999Journal of natural products, Apr, Volume: 62, Issue:4
10'-Hydroxyusambarensine, a new antimalarial bisindole alkaloid from the roots of Strychnos usambarensis.
AID358511Selectivity index, ratio of IC50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum W2 Indochina2001Journal of natural products, Jan, Volume: 64, Issue:1
Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja.
AID379451Antiplasmodial activity after 36 hrs against chloroquine-sensitive Plasmodium falciparum FCA 20 in human erythrocytes by [3H]hypoxanthine uptake1999Journal of natural products, Apr, Volume: 62, Issue:4
10'-Hydroxyusambarensine, a new antimalarial bisindole alkaloid from the roots of Strychnos usambarensis.
AID358509Cytotoxicity against human WI38 cells by WST1 assay2001Journal of natural products, Jan, Volume: 64, Issue:1
Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja.
AID358513Selectivity index, ratio of IC50 for human WI38 cells to IC50 for chloroquine-resistant Plasmodium falciparum W2 Indochina2001Journal of natural products, Jan, Volume: 64, Issue:1
Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]